Showing 421 - 440 results of 3,069 for search '"hypertension"', query time: 0.06s Refine Results
  1. 421

    Vitamin D Supplementation and Hemoglobin Levels in Hypertensive Patients: A Randomized Controlled Trial by Jana B. Ernst, Andreas Tomaschitz, Martin R. Grübler, Martin Gaksch, Katharina Kienreich, Nicolas Verheyen, Winfried März, Stefan Pilz, Armin Zittermann

    Published 2016-01-01
    “…We evaluated whether vitamin D supplementation improves Hb levels and reduces anemia risk in hypertensive patients. Two hundred patients with 25OHD levels <75 nmol/L who attended the Styrian Vitamin D Hypertension Trial were included, of whom 188 completed the trial. …”
    Get full text
    Article
  2. 422

    Interleukin-1β Accelerates the Onset of Stroke in Stroke-Prone Spontaneously Hypertensive Rats by Tsuyoshi Chiba, Tatsuki Itoh, Masaki Tabuchi, Toru Nakazawa, Takao Satou

    Published 2012-01-01
    “…These results suggest that a stimulated IL-1β signal might be a cause of stroke onset when concomitant with severe hypertension.…”
    Get full text
    Article
  3. 423

    Polypharmacy in Patients with Type 2 Diabetes and Arterial Hypertension Treated in a Provincial Hospital by José Ander Asenjo Alarcón

    Published 2022-11-01
    “…<br /><strong>Results</strong>: 72.3 % of patients were women, their mean age was 68.6 years, the consumption of 4 drugs was the average for the comorbidity of type 2 diabetes and arterial hypertension, followed by 3 drugs in arterial hypertension, which represented polypharmacy for both cases (30.2 and 23.8 %, respectively). …”
    Get full text
    Article
  4. 424
  5. 425
  6. 426

    Risk Assessment of Dyslipidemias, Hyperglycemia, Hyperuricemia, and Hypertension Utilizing Self-Reported Body Silhouettes by Ruben Blachman-Braun, Juan O. Talavera, Marcela Pérez-Rodríguez, Ivonne Roy-García, Rodolfo Rivas-Ruiz, Gerardo Huitrón-Bravo, Jorge Salmerón

    Published 2023-01-01
    “…Then, risk analysis was performed considering dyslipidemias as serum triglycerides, high total cholesterol, high LDL-C, low HDL-C, hyperglycemia, hyperuricemia, and hypertension. Results. A total of 2,297 males and 5,003 females were analyzed. …”
    Get full text
    Article
  7. 427

    Artificial intelligence driven clustering of blood pressure profiles reveals frailty in orthostatic hypertension by Claire M. Owen, Jaume Bacardit, Maw P. Tan, Nor I. Saedon, Choon‐Hian Goh, Julia L. Newton, James Frith

    Published 2025-02-01
    “…Furthermore, our findings support orthostatic hypertension as a distinct clinical entity, with frailty implications suggesting that it is worthy of further investigation.…”
    Get full text
    Article
  8. 428
  9. 429

    In Situ Thrombosis of Small Pulmonary Arteries in Pulmonary Hypertension Developing after Chemotherapy for Malignancy by Kay Maeda, Yoshikatsu Saiki, Shigeo Yamaki

    Published 2015-01-01
    “…A few reports have provided histopathological insight into pulmonary hypertension developing after antitumor chemotherapy. …”
    Get full text
    Article
  10. 430
  11. 431

    Transition from Hepatopulmonary Syndrome to Portopulmonary Hypertension: A Case Series of 3 Patients by Radhika Zopey, Irawan Susanto, Igor Barjaktarevic, Tisha Wang

    Published 2013-01-01
    “…Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPHTN) are the two major pulmonary vascular complications of liver disease. …”
    Get full text
    Article
  12. 432
  13. 433
  14. 434
  15. 435

    Prevalence of Systemic Arterial Hypertension Diagnosed, Undiagnosed, and Uncontrolled in Elderly Population: SABE Study by Isabela Martins Oliveira, Yeda Aparecida de Oliveira Duarte, Dirce Maria Trevisan Zanetta

    Published 2019-01-01
    “…Systemic arterial hypertension is the most prevalent chronic noncommunicable disease among older people. …”
    Get full text
    Article
  16. 436

    Effect of Transcriptional Regulator ID3 on Pulmonary Arterial Hypertension and Hereditary Hemorrhagic Telangiectasia by Vincent Avecilla

    Published 2019-01-01
    “…Pulmonary arterial hypertension (PAH) can be discovered in patients who have a loss of function mutation of activin A receptor-like type 1 (ACVRL1) gene, a bone morphogenetic protein (BMP) type 1 receptor. …”
    Get full text
    Article
  17. 437
  18. 438
  19. 439
  20. 440